Health Care & Life Sciences » Biotechnology | Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,919.00
-
19,769.00
15,000.00
161,626.00
451,240
Cost of Goods Sold (COGS) incl. D&A
671.00
827.00
-
-
2,454.00
4,889
Gross Income
2,248.00
827.00
-
-
159,172.00
446,351
SG&A Expense
51,926.00
63,584.00
112,962.00
160,872.00
290,533.00
409,456
EBIT
49,678.00
64,411.00
94,202.00
147,372.00
131,361.00
36,895
Non Operating Income/Expense
3,188.00
3,240.00
3,345.00
3,444.00
2,104.00
700
Interest Expense
-
-
-
-
19,523.00
30,530
Pretax Income
46,090.00
60,542.00
88,929.00
141,090.00
142,542.00
21,841
Consolidated Net Income
46,090.00
60,542.00
88,929.00
141,090.00
142,542.00
21,111
Net Income
46,090.00
60,542.00
88,929.00
141,090.00
142,542.00
21,111
Net Income After Extraordinaries
46,090.00
60,542.00
88,929.00
141,090.00
142,542.00
21,111
Net Income Available to Common
46,090.00
60,542.00
88,929.00
141,090.00
142,542.00
21,111
EPS (Basic)
0.69
0.81
1.05
1.63
1.62
0.22
Basic Shares Outstanding
66,989.00
74,577.00
84,496.00
86,713.00
88,089.00
90,235
EPS (Diluted)
0.69
0.81
1.05
1.63
1.62
0.22
Diluted Shares Outstanding
66,989.00
74,577.00
84,496.00
86,713.00
88,089.00
95,386
EBITDA
49,007.00
63,584.00
93,193.00
145,872.00
128,961.00
40,919
Non-Operating Interest Income
400.00
629.00
1,928.00
2,838.00
6,238.00
14,776

About Neurocrine Biosciences

View Profile
Address
12780 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.neurocrine.com
Updated 07/08/2019
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.